Bgm Group Ltd stock is traded at $9.00, with a volume of 29,389. It is down -5.66% in the last 24 hours and down -3.74% over the past month. BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
Previous Close:
$9.54
Open:
$7.95
24h Volume:
29,389
Relative Volume:
1.88
Market Cap:
$120.19M
Revenue:
$26.85M
Net Income/Loss:
-$2.67M
P/E Ratio:
-
EPS:
-$0.2842
Net Cash Flow:
-$9.38M
1W Performance:
-5.66%
1M Performance:
-3.74%
6M Performance:
+2.15%
1Y Performance:
-96.97%
1-Day Range:
$7.95$9.56
1-Week Range:
$7.95$9.56
52-Week Range:
$6.45$302.40
Bgm Group Ltd Stock (BGM) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS